First reports of adverse drug reactions: First reports of adverse drug reactions.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 3, p. 110, doi. 10.1007/s40267-025-01139-3
- Publication type:
- Article
Works matching IS 11720360 AND DT 2025 AND VI 41 AND IP 3
Results: 6
1
2
Regulatory and clinical aspects in biosimilar medicines: comparability, extrapolation, interchangeability, and safety: Biosimilar medicines: evaluating comparability, extrapolation, interchangeability, and safety: M. C. Raposo et al.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 3, p. 111, doi. 10.1007/s40267-025-01145-5
- By:
- Publication type:
- Article
3
Consider patient characteristics when treating compulsive sexual behaviour.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 3, p. 106, doi. 10.1007/s40267-025-01143-7
- By:
- Publication type:
- Article
4
Look for glaucoma, especially in elderly, and match therapies to patients.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 3, p. 89, doi. 10.1007/s40267-025-01142-8
- By:
- Publication type:
- Article
5
Continue to treat sarcopenia with exercise and diet while potential pharmacotherapies are under investigation.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 3, p. 94, doi. 10.1007/s40267-025-01141-9
- By:
- Publication type:
- Article
6
Diagnose childhood interstitial lung disease in a stepwise manner and treat according to the aetiology of the associated condition.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 3, p. 101, doi. 10.1007/s40267-024-01135-z
- By:
- Publication type:
- Article